Bio-Techne Corporation
TECH
Rankning i aktier
#1871
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures,... Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Spatial Biology. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow consists of manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications; and sells products for genetic carrier screening, oncology diagnostics, molecular controls, and research, as well as instruments and process control products for hematology, blood chemistry and gases, and coagulation controls and reagents used in various diagnostic applications. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was incorporated in 1976 and is headquartered in Minneapolis, Minnesota.
Aktiekurs
$72.49
Marknadsvärde
$11.37B
Förändring (1 dag)
-0.12%
Förändring (1 år)
17.18%
Land
US
Handel Bio-Techne Corporation (TECH)
Kategori
Healthcare
P/E-tal för Bio-Techne Corporation (TECH)
P/E-tal per October 2026 TTM: 61.97
Enligt Bio-Techne Corporation senaste finansiella rapporter och aktiekurs är det aktuella P/E-talet (TTM) 61.97. I slutet av 2024 hade företaget ett P/E-tal på 67.18.
Historik för P/E-tal för Bio-Techne Corporation från 2000 till 2026
P/E-tal vid slutet av varje år
| År | P/E-tal | Ändra |
|---|---|---|
| 2026 (TTM) | 61.97 | -43.88% |
| 2025 | 110.41 | 64.35% |
| 2024 | 67.18 | 49.36% |
| 2023 | 44.98 | -9.99% |
| 2022 | 49.97 | -59.78% |
| 2021 | 124.26 | 182.43% |
| 2020 | 44.00 | -46.54% |
| 2019 | 82.30 | 86.05% |
| 2018 | 44.24 | -22.03% |
| 2017 | 56.74 | 41.34% |
| 2016 | 40.14 | 18.38% |
| 2015 | 33.91 | 10.18% |
| 2014 | 30.78 | 34.96% |
| 2013 | 22.80 | -6.55% |
| 2012 | 24.40 | -11.39% |
| 2011 | 27.54 | 41.26% |
| 2010 | 19.49 | -14.94% |
| 2009 | 22.92 | -21.66% |
| 2008 | 29.25 | 10.46% |
| 2007 | 26.48 | -2.30% |
| 2006 | 27.11 | -3.27% |
| 2005 | 28.02 | -16.81% |
| 2004 | 33.69 | 21.76% |
| 2003 | 27.67 | -35.05% |
| 2002 | 42.59 | 7.61% |
| 2001 | 39.58 | -60.15% |
| 2000 | 99.34 | 0.00% |
P/E-tal för liknande företag eller konkurrenter
| Företag | P/E-tal | Skillnad i P/E-tal | Land |
|---|---|---|---|
| 28.78 | -53.55% |
US
|
|
| -28.36 | -145.76% |
US
|
|
| -24.57 | -139.65% |
AU
|
|
| - | - |
CH
|
|
| 30.33 | -51.05% |
NL
|
Hur man läser ett P/E-tal
P/E-talet (Price/Earnings) mäter förhållandet mellan ett företags aktiekurs och dess vinst per aktie.
Ett lågt men positivt P/E visar ett företag med hög vinst i förhållande till värderingen och kan vara undervärderat. Ett högt negativt (nära 0) P/E indikerar stora förluster.
Företag med P/E över 30 eller negativt ses ofta som "tillväxtaktier", vilket innebär att investerare förväntar sig tillväxt eller framtida lönsamhet.
Företag med positivt P/E under 10 ses som "värdeaktier" och är redan lönsamma men med begränsad tillväxtpotential.